###begin article-title 0
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA-</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain
###end article-title 0
###begin p 1
###xml 17 22 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA)</italic>
###xml 160 164 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 216 221 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA-</italic>
###xml 407 411 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 450 454 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 508 512 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 586 590 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 747 751 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 823 827 819 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 841 845 837 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1330 1335 1326 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA-</italic>
###xml 1519 1523 1515 1519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
###xml 835 840 <span type="species:ncbi:9606">Human</span>
###xml 1108 1113 <span type="species:ncbi:10090">mouse</span>
###xml 1129 1134 <span type="species:ncbi:9606">human</span>
###xml 1324 1329 <span type="species:ncbi:9606">human</span>
###xml 1370 1376 <span type="species:ncbi:10090">murine</span>
###xml 1461 1465 <span type="species:ncbi:10090">mice</span>
###xml 1513 1518 <span type="species:ncbi:9606">human</span>
alpha-Synuclein (SNCA) gene has been implicated in the development of rare forms of familial Parkinson disease (PD). Recently, it was shown that an increase in SNCA copy numbers leads to elevated levels of wild-type SNCA-mRNA and protein and is sufficient to cause early-onset, familial PD. A critical question concerning the molecular pathogenesis of PD is what contributory role, if any, is played by the SNCA gene in sporadic PD. The expansion of SNCA-Rep1, an upstream, polymorphic microsatellite of the SNCA gene, is associated with elevated risk for sporadic PD. However, whether SNCA-Rep1 is the causal variant and the underlying mechanism with which its effect is mediated by remained elusive. We report here the effects of three distinct SNCA-Rep1 variants in the brains of 72 mice transgenic for the entire human SNCA locus. Human SNCA-mRNA and protein levels were increased 1.7- and 1.25-fold, respectively, in homozygotes for the expanded, PD risk-conferring allele compared with homozygotes for the shorter, protective allele. When adjusting for the total SNCA-protein concentration (endogenous mouse and transgenic human) expressed in each brain, the expanded risk allele contributed 2.6-fold more to the SNCA steady-state than the shorter allele. Furthermore, targeted deletion of Rep1 resulted in the lowest human SNCA-mRNA and protein concentrations in murine brain. In contrast, the Rep1 effect was not observed in blood lysates from the same mice. These results demonstrate that Rep1 regulates human SNCA expression by enhancing its transcription in the adult nervous system and suggest that homozygosity for the expanded Rep1 allele may mimic locus multiplication, thereby elevating PD risk.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 17 22 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA)</italic>
###xml 140 141 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C1">1</xref>
###xml 142 143 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C3">3</xref>
###xml 173 174 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C4">4</xref>
###xml 175 176 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C8">8</xref>
###xml 370 374 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 406 407 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C9">9</xref>
###xml 465 469 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 539 546 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 635 639 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 680 684 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 939 940 935 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C5">5</xref>
###xml 941 942 937 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C8">8</xref>
###xml 943 945 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C10">10</xref>
###xml 946 948 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C11">11</xref>
###xml 1287 1289 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C12">12</xref>
###xml 1342 1344 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C13">13</xref>
###xml 1366 1370 1362 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1434 1436 1430 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C14">14</xref>
###xml 1490 1492 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C15">15</xref>
###xml 1551 1555 1547 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 107 110 <span type="species:ncbi:9606">Man</span>
###xml 1072 1077 <span type="species:ncbi:9606">human</span>
alpha-Synuclein (SNCA) (GenBank: AF163864; Ensembl: ENSG00000145335; OMIM, Online Mendelian Inheritance in Man: MIM 163890) gene mutations (1-3) and copy number variations (4-8) have been implicated in the development of rare forms of familial Parkinson disease (PD, MIM 168600). Moreover, a recent genome-wide association study provided further support for the role of SNCA in familial PD susceptibility (9). Recently published evidence showed that an increase in SNCA copy numbers leads to elevated levels of wild-type (WT) SNCA protein in vivo and is sufficient to cause early-onset, familial PD. Whereas the triplication of the WT SNCA locus leads to 2-fold overexpression of SNCA-mRNA and protein, duplication results in a 1.5-fold elevation. Duplication results in lower penetrance than is seen with triplication, a slightly later onset of the disease and a 'milder' phenotype that is essentially indistinguishable from sporadic PD (5-8,10,11). Furthermore, PD, dementia with Lewy bodies (DLB, MIM 127750) and multiple system atrophy (MSA) are seen as prototypes of human 'synucleinopathies', which are characterized by intracellular SNCA inclusions. These aggregates have been identified in neuronal Lewy bodies and neurites, two pathological hallmark lesions of both PD and DLB (12), and in glial inclusions, a characteristic of MSA (13). Moreover, elevated SNCA-mRNA levels have been reported in midbrain tissue homogenates (14) and in dopaminergic neurons from sporadic PD cases (15). These observations emphasize the critical importance of SNCA dosage and expression levels in the pathogenesis of PD and related synucleinopathies.
###end p 3
###begin p 4
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 193 215 193 215 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://www.pdgene.org/">http://www.pdgene.org/</uri>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C16">16</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C19">19</xref>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 420 422 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C20">20</xref>
###xml 423 425 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C21">21</xref>
###xml 552 556 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 624 626 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C22">22</xref>
###xml 627 629 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C25">25</xref>
###xml 850 854 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1027 1029 1015 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C26">26</xref>
###xml 1030 1032 1018 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C27">27</xref>
###xml 1065 1069 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1351 1355 1339 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1421 1424 1409 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1479 1483 1467 1471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1530 1534 1518 1522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1609 1611 1597 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C28">28</xref>
###xml 1588 1593 <span type="species:ncbi:9606">human</span>
Several association studies have demonstrated that genetic variability across the SNCA locus, including its promoter, is associated with altered susceptibility to sporadic PD (PDGene database, http://www.pdgene.org/) (16-19). To date, the most studied SNCA genetic variation is Rep1 (GenBank D4S3481), a complex polymorphic microsatellite repeat site located approximately10 kb upstream of the transcription start site (20,21). The overwhelming majority of these association studies, including a large meta-analysis, have shown that certain alleles of SNCA-Rep1 confer increased risk to develop late-onset, 'idiopathic' PD (22-25). Previously, we attempted to determine whether this genetic association correlated with any biological function. Using a reporter assay in a transiently transfected neuronal cell culture model, we demonstrated that the SNCA-Rep1 had a reproducible effect on regulating transcriptional activity; there, certain allele lengths showed a nearly 3-fold change in expression of the reporter construct (26,27). Given that multiplications of SNCA have been implicated in heritable PD, where elevated dosage increases penetrance and lowers age-of-onset, we hypothesized that a subtle increase in SNCA expression over decades confers an elevated risk for late-onset, sporadic PD. We posited that the strong genetic association of SNCA-Rep1 allele expansion with PD risk could be the consequence of a cis-acting mechanism on the transcriptional regulation of SNCA. Moreover, it was recently suggested that the SNCA-Rep1 genotype may also affect SNCA protein levels in human blood samples (28).
###end p 4
###begin p 5
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 175 179 175 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 191 198 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C22">22</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C23">23</xref>
###xml 524 528 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 657 661 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 877 881 853 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 887 894 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 722 737 <span type="species:ncbi:10090">transgenic mice</span>
Here, we used a transgenic mouse model to examine three distinct Rep1 variants within the human SNCA locus to establish the relevance of the Rep1 element in the regulation of SNCA expression in vivo. We engineered the two most frequent alleles that have been reported in both Caucasian and Asian populations (22,23), i.e. the expanded, 261 bp-long Rep1 allele (approximately68% in control whites) and its shorter 259 bp variant (approximately27%), into a bacterial P1 artificial chromosome (PAC) containing the entire human SNCA gene. We also engineered an artificial allele consisting of a deletion of the Rep1 repeat within the same PAC. We then compared SNCA-mRNA and protein levels in the brain and blood specimens of transgenic mice carrying the 261 and 259 bp and the Rep1-deletion alleles in order to compare the effect of the different alleles on the expression of the SNCA gene in vivo.
###end p 5
###begin title 6
RESULTS
###end title 6
###begin title 7
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Characterization of transgenic mouse lines to examine three distinct SNCA-Rep1 genotypes
###end title 7
###begin p 8
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 290 291 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F1">1</xref>
###xml 353 357 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 506 508 494 496 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 511 512 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 516 518 504 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 522 523 510 511 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 527 529 515 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 538 540 526 528 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 543 544 531 532 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 548 550 536 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 554 555 542 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 559 561 547 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 616 620 604 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1104 1108 1076 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1235 1236 1207 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F2">2</xref>
###xml 1257 1264 1229 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1470 1471 1442 1443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F2">2</xref>
###xml 1698 1700 1670 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C29">29</xref>
###xml 13 28 <span type="species:ncbi:10090">transgenic mice</span>
###xml 139 144 <span type="species:ncbi:9606">human</span>
###xml 1098 1103 <span type="species:ncbi:9606">human</span>
###xml 1116 1121 <span type="species:ncbi:10090">mouse</span>
###xml 1687 1692 <span type="species:ncbi:9606">human</span>
We generated transgenic mice lines for three distinct SNCA-Rep1 genotypes carrying the 146 kb-large PAC 27M07. The PAC contains the entire human SNCA gene and 34 kb of its upstream region, including the SNCA-Rep1 site located within approximately10 kb of the transcription start site (Fig. 1). Each genotype examined contained a different allele at the SNCA-Rep1 site. These included the two naturally occurring variants, Rep1-261 bp and Rep1-259 bp, which carried the following sequence combinations, (TC)10(T)2(TC)10(TA)8(CA)11 and (TC)10(T)2(TC)10(TA)8(CA)10, respectively, and one artificial allele in which the SNCA-Rep1 repeat has been deleted altogether, Delta-Rep1. Importantly, these PAC clones harbored approximately34 kb of non-coding DNA located upstream of exon 1, thereby reducing possible integration site effects on transcription. Nevertheless, to further minimize any confounding effect of genome integration site by our PAC variants on subsequent transgene expression, we decided to generate two independent lines for each of the three genotypes. Transcription and translation of human SNCA in the mouse brain was confirmed at the F1 generation, as shown, for example, in the Rep1-261/261-carrying line 'A' in Figure 2B and C. Fluorescent in situ hybridization (FISH) was used to determine the chromosomal integration site of each line () and to obtain a first estimate for the range of genomic copy numbers (see, for example, 261/261 line 'A' in Fig. 2A). The precise copy number in each line was then determined more accurately. To this end, we employed quantitative real-time PCR using genomic DNA from animals in each line by targeting two different regions of the human PAC (29). We calculated that the relative transgene copy numbers in the different lines shown here ranged from 1 to 7 transgene copies per haploid genome ().
###end p 8
###begin p 9
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
###xml 112 117 <span type="species:ncbi:9606">human</span>
A schematic presentation of the PAC (27M07) used to generate the transgenic mice lines. The organization of the human SNCA locus that is included in the PAC at the top panel. The three distinct SNCA-Rep1 genotypes are indicated below.
###end p 9
###begin p 10
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 482 483 482 483 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 596 597 596 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 987 989 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C55">55</xref>
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:10090">mouse</span>
###xml 344 349 <span type="species:ncbi:9606">human</span>
###xml 375 380 <span type="species:ncbi:10090">mouse</span>
###xml 402 407 <span type="species:ncbi:10090">mouse</span>
###xml 555 560 <span type="species:ncbi:9606">human</span>
###xml 588 593 <span type="species:ncbi:10090">mouse</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 650 655 <span type="species:ncbi:9606">human</span>
###xml 711 716 <span type="species:ncbi:9606">human</span>
###xml 744 749 <span type="species:ncbi:10090">mouse</span>
###xml 816 821 <span type="species:ncbi:10090">mouse</span>
###xml 864 869 <span type="species:ncbi:10090">mouse</span>
###xml 1030 1035 <span type="species:ncbi:9606">human</span>
Serial analyses to confirm the mouse lines in the study. Presented is an example analysis performed for transgenic line 'A', carrying the human SNCA-Rep1 261 bp allele. (A) FISH analysis of metaphase chromosomes obtained from the mouse's spleen was used to determine the insertion site and to estimate the range of the copy number. Red-labeled human-PAC 27M07; green-labeled mouse BAC corresponding to mouse chromosome 9, used as a reference for copy number estimation; blue-DAPI. (B) RT-PCR to the 27M07 PAC was used to confirm the RNA expression of the human SNCA in the brain of an F1 mouse. (C) Western blot using the mouse monoclonal LB509 anti-human-SNCA (Zymed), to confirm the protein expression of the human SNCA in the brain of an F1 mouse. For (B) and (C), each lane represents analysis performed using a mouse-brain sample harvested from the following mouse lines: Rep1 261-A, the 261/261 line 'A' transgenic; PAC, control PAC containing the original Rep1 allele transgenic (55); Wt, wild type FVB; hSNCA, recombinant human SNCA protein.
###end p 10
###begin p 11
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 479 483 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 86 101 <span type="species:ncbi:10090">transgenic mice</span>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
Next we analyzed human SNCA expression levels in the brain and blood of F2 homozygous transgenic mice and in the heterozygous Delta-Rep1 line 'B'. A total of 72 F2 animals from six mouse lines, representing two F2 lines for each of the three distinct alleles (e.g. Rep1-261 bp, Rep1-259 bp and Delta-Rep1 deletion), were sacrificed at the age of 8 weeks; these mice were used for extended quantitative analyses at the mRNA and protein level to determine their variation in human SNCA expression, as controlled by each PAC transgene.
###end p 11
###begin title 12
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Effects of Rep1 variants on human SNCA-mRNA levels in mouse brain
###end title 12
###begin p 13
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA-</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 301 304 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 336 344 336 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 351 352 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F3">3</xref>
###xml 711 715 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 740 741 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F3">3</xref>
###xml 862 865 856 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 930 934 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1063 1064 1049 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F3">3</xref>
###xml 1222 1226 1208 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1344 1345 1330 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1401 1405 1387 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1443 1444 1429 1430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 651 666 <span type="species:ncbi:10090">transgenic mice</span>
###xml 760 764 <span type="species:ncbi:10090">mice</span>
###xml 856 861 <span type="species:ncbi:10090">mouse</span>
###xml 1041 1056 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1216 1221 <span type="species:ncbi:9606">human</span>
###xml 1279 1283 <span type="species:ncbi:10090">mice</span>
To study the effect of SNCA-Rep1 allele homozygosity on human SNCA-mRNA levels in transgenic mouse brain (n = 72), we employed a real-time PCR assay specific for the human message (no amplification was detected with the control WT mouse). All levels were measured relative to the mouse synaptophysin (Syp) endogenous reference gene by 2-DeltaCt (Fig. 3A). The fold expression levels of each mouse line () were then corrected according to copy number values, and the average fold expression for each of the three transgenes was determined. Our calculations, which are expressed as fold expression per diploid-copy of the transgene, showed that 261/261 transgenic mice consistently generated the highest level of SNCA-mRNA in the brain (Fig. 3B; ). Rep1 261/261 mice demonstrated an average 0.27 +/- 0.04-fold expression level relative to that of endogenous mouse Syp compared with an average 0.16 +/- 0.03-fold expression level of SNCA-mRNA in the 259/259 transgenic lines and an average 0.08 +/- 0.06-fold expression level in the Delta-Rep1 transgenic mice (Fig. 3B). From these results, we calculated that the mice, which carried the PD risk-associated allele Rep1-261 bp, harbored significantly elevated levels of human SNCA-mRNA, amounting to a nearly 70% increase over those mice that carried the 'protective' genotype, allele Rep1-259 bp (P < 0.0001). No significant correlation was seen between SNCA-mRNA levels in the brain and gender (P = 0.44).
###end p 13
###begin p 14
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 193 197 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 279 283 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 294 297 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 386 390 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 395 398 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 513 514 501 502 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 537 541 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 613 616 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 651 659 639 643 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 704 708 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 845 849 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 900 901 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 925 929 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 978 982 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1031 1032 1015 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 215 220 <span type="species:ncbi:10090">mouse</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
###xml 288 293 <span type="species:ncbi:10090">mouse</span>
###xml 531 536 <span type="species:ncbi:9606">human</span>
###xml 607 612 <span type="species:ncbi:10090">mouse</span>
###xml 698 703 <span type="species:ncbi:9606">human</span>
###xml 745 750 <span type="species:ncbi:10090">mouse</span>
###xml 1056 1060 <span type="species:ncbi:10090">mice</span>
Effect of the SNCA-Rep1 promoter genotypes on human SNCA-mRNA expression levels in transgenic mouse brains. (A) Validation curve of the Delta real-time assay for relative quantization of human SNCA-mRNA relative to mouse Syp-mRNA in the brain. Relative efficiency plots of human-SNCA and mouse-Syp were formed by plotting the log input amount (ng of total RNA) versus the DeltaCt = [Ct(SNCA)-Ct(Syp)]. The slope is 0.045, which indicated the validation of the DeltaCt calculation in the range of 0.1-100 ng RNA. (B) Fold levels of human SNCA-mRNA were assayed by real-time RT-PCR and calculated relative to mouse Syp-mRNA reference control using the 2-DeltaCt method. No detectable products of the human SNCA-mRNA reaction were observed when WT mouse brain-cDNA was used as template. The risk genotype 261/261 correlates with significant higher SNCA-mRNA levels than the protective genotype 259/259 (P < 0.0001). The deleted SNCA-Rep1 genotype correlates with significant lower SNCA-mRNA levels than genotypes 261/261 and 259/259 (P< 0.0001). In total, 72 mice were analyzed; for each genotype (261/261, 259/259 and Delta/Delta), the box plot represents the analysis performed using two transgenic lines, 12 animals from each line (6 males and 6 females), comprising 24 total brain samples per genotype, each of which was analyzed twice independently. The average values are presented by 'X'. The box plot shows the median (horizontal line inside the box) and the 25th and 75th percentiles (horizontal borders of the box). The range between the 25th and 75th percentiles is the interquartile range. The whiskers show the minimal and maximal values inside the main data body.
###end p 14
###begin p 15
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 362 363 362 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F3">3</xref>
###xml 475 479 475 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 186 201 <span type="species:ncbi:10090">transgenic mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
In addition, we aimed to study the overall effect of the presence or absence of the Rep1 microsatellite site on the regulation of SNCA-mRNA expression. SNCA-mRNA levels in the brains of transgenic mice carrying the SNCA-Rep1 deletion were significantly lower when compared with mice carrying the naturally occurring alleles 261/261 and 259/259 (P < 0.0001; Fig. 3B; ). The latter result suggested that in the brain tissue, Rep1 might act as an enhancer element to upregulate SNCA-mRNA levels.
###end p 15
###begin title 16
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Effects of Rep1 variants on human SNCA protein concentrations in mouse brain
###end title 16
###begin p 17
###xml 211 212 211 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C30">30</xref>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C31">31</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F4">4</xref>
###xml 876 877 876 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F4">4</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C31">31</xref>
###xml 884 886 884 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 1536 1537 1520 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1553 1554 1537 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F5">5</xref>
###xml 1717 1718 1691 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F5">5</xref>
###xml 61 66 <span type="species:ncbi:9606">human</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 424 430 <span type="species:ncbi:10090">murine</span>
###xml 858 863 <span type="species:ncbi:10090">mouse</span>
###xml 966 972 <span type="species:ncbi:9986">rabbit</span>
###xml 996 1001 <span type="species:ncbi:9606">human</span>
###xml 1111 1116 <span type="species:ncbi:9606">human</span>
###xml 1130 1135 <span type="species:ncbi:10090">mouse</span>
###xml 1371 1376 <span type="species:ncbi:9606">human</span>
###xml 1411 1416 <span type="species:ncbi:10090">mouse</span>
###xml 1504 1508 <span type="species:ncbi:10090">mice</span>
###xml 1630 1635 <span type="species:ncbi:9606">human</span>
###xml 1680 1684 <span type="species:ncbi:10090">mice</span>
In parallel to these mRNA measurements, we also analyzed the human SNCA protein content in brain homogenates of 12 age- and gender-matched mice from each of the six lines representing the three genotypes (total n = 72). We focused on the pool of 'soluble' SNCA protein that are found in the neuronal cytosol and membrane-associated compartments, which encompass the overwhelming majority of available SNCA proteins in young murine brain (in contrast to the low amount that is present in 'insoluble' compartments at that age) (30, 31). Following the observation of variable SNCA signals in routine western blotting experiments (Fig. 4A), which represents a low throughput and non-linear method of signal detection, we employed an extensively validated, sandwich-type enzyme-linked immunoadsorbent assay (ELISA) protocol for the quantification of SNCA in each mouse brain (Fig. 4B) (31-33). Using ELISA pair [hSA3/211-B], which combines a sensitive, affinity-purified rabbit antibody [hSA3] with a human SNCA-specific monoclonal antibody (mAb) (211), we first calculated the absolute concentration (ng/microl) of human SNCA in each mouse homogenate (); these values were then corrected for the gene copy number in each line to determine the protein concentration per one diploid-copy of the transgene. Consistent with our mRNA results, we recorded a 1.25-fold elevation in human SNCA levels in 261/261 transgenic mouse brain (0.71 +/- 0.30 ng/microl homogenate) over the protective 259/259 allele carrying mice (0.57 +/- 0.56 ng/microl) (P = 0.0004; Fig. 5A). As expected from the mRNA data (see above), the lowest concentration of human SNCA was recorded in the Delta-Rep-carrying mice (0.17 +/- 0.27 ng/microl) (Fig. 5A).
###end p 17
###begin p 18
###xml 88 89 88 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 887 891 887 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snca</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 795 800 <span type="species:ncbi:9606">human</span>
###xml 902 907 <span type="species:ncbi:10090">mouse</span>
###xml 965 970 <span type="species:ncbi:9606">human</span>
###xml 1014 1019 <span type="species:ncbi:10090">mouse</span>
###xml 1082 1088 <span type="species:ncbi:10090">murine</span>
###xml 1093 1098 <span type="species:ncbi:9606">human</span>
###xml 1153 1158 <span type="species:ncbi:9606">human</span>
Analyzing SNCA proteins in F2 transgenic mouse brains. Representative western blotting (A) and ELISA (B) results from 24 age- and gender-matched F2 transgenic mouse brains are shown for the three distinct genotypes in six mouse lines. Specimens were assayed with a combination of polyclonal (pAb) and monoclonal (mAb) anti-SNCA antibodies. Equal volumes of whole-brain extracts were either directly loaded onto reducing SDS-PAGE (A) or first adjusted for their total protein content, then diluted at 1: 5000 and subsequently loaded onto ELISA plates (B). Sandwich ELISA (hSA-3/211-B; red bars to the right of each pair) and ELISA (hSA-3/Syn1-B; blue bars on the left of each pair) were carried out on the same 384-well plate in triplicates. Note the near identical monitoring of the recombinant human SNCA protein standards by both assays (left); the absence of any absorbance signal in snca-null (KO) mouse brain by either assay and the absence of signal with the human SNCA-specific ELISA in WT (non-transgenic) mouse brain (center); the fact that the total SNCA signal measuring murine and human protein (blue bars, left) is always stronger than the human-specific signal alone (red bars, right).
###end p 18
###begin p 19
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 4 5 4 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 78 79 78 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 588 589 576 577 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 428 433 <span type="species:ncbi:10090">mouse</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
###xml 790 795 <span type="species:ncbi:10090">mouse</span>
###xml 805 810 <span type="species:ncbi:9606">human</span>
SNCA-Rep1 expansion increases SNCA protein concentration in mammalian brain. (A) Quantification of human SNCA protein in transgenic mouse brain homogenates using sandwich ELISA [hSA-3/211-B] and a 384-well plate format (triplicates; 50 microl/well); a total of 72 mice were analyzed. Concentration values (in ng/microl) were interpolated from the standard curve () and then corrected for the calculated gene copy number in each mouse line. Values were grouped according to the three genotypes examined, i.e. Rep1-261 bp; Rep1-259 bp; Delta-Rep1 (ratio: female:male, 50:50 in all lines). (B) Relative ratio of the human SNCA concentration (as shown in A) to the total SNCA protein concentration. The latter was measured using sandwich ELISA [hSA3/Syn1-B] on 384-well plates quantifying both mouse Snca and human SNCA (; after correction for gene copy number: ). Bar graph shown in (B) represents values obtained in (A) divided by those shown in .
###end p 19
###begin p 20
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snca</italic>
###xml 464 466 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 474 475 467 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F4">4</xref>
###xml 1101 1102 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1118 1119 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F5">5</xref>
###xml 1493 1496 1460 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 1520 1524 1487 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 64 70 <span type="species:ncbi:10090">murine</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 205 210 <span type="species:ncbi:10090">mouse</span>
###xml 479 484 <span type="species:ncbi:10090">Mouse</span>
###xml 587 592 <span type="species:ncbi:9606">human</span>
###xml 597 602 <span type="species:ncbi:10090">mouse</span>
###xml 890 895 <span type="species:ncbi:9606">human</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
###xml 1219 1224 <span type="species:ncbi:10090">mouse</span>
###xml 1591 1596 <span type="species:ncbi:9606">human</span>
To control for any variability in the expression of endogenous, murine snca, which could have affected transgene penetrance, we next calculated the relative abundance of human versus total (i.e. human and mouse) SNCA in the same brain homogenates. To this end, we employed our sandwich ELISA protocol [hSA3/Syn1-B], which reproducibly quantifies total SNCA from both rodent and primate sources and does not cross-react with beta- or with gamma-synuclein proteins (33) (Fig. 4B). Mouse lines carrying the expanded Rep1-261 bp allele showed the highest total SNCA concentration (measuring human and mouse variants, i.e. 6.17 +/- 2.53 ng/microl homogenate), followed by lines that carry the protective Rep1-259 bp genotype (5.63 +/- 4.74 ng/microl), followed by those carrying the Delta-Rep1 allele (4.74 +/- 2.02 ng/microl) (). In accordance with the above, we recorded the highest ratio of 'human-to-total SNCA concentrations' following copy number corrections in brains from 261/261 mice (average ratio 0.80), followed by 259/259 animals (average ratio 0.31) and Delta-Rep1 mice (average ratio 0.13) (P < 0.0001; Fig. 5B; ). The findings of relative and absolute SNCA concentration differences between these transgenic mouse lines remained the same when the ELISA operator was blinded to their respective genotypes (not shown). As in our mRNA studies before, we did not observe a gender effect on neural SNCA protein concentrations. We concluded from these data that the Rep1 region acts as a cis-regulatory enhancer of SNCA transcription, thereby effectively modulating the steady state of human SNCA in the mammalian brain.
###end p 20
###begin title 21
###xml 34 38 34 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Effects of Rep1 variants on human SNCA-mRNA levels in mouse blood
###end title 21
###begin p 22
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 113 114 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 270 272 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C32">32</xref>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C34">34</xref>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 622 623 622 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F6">6</xref>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 991 992 991 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F6">6</xref>
###xml 1121 1122 1121 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F6">6</xref>
###xml 1179 1183 1179 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1208 1209 1208 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 96 111 <span type="species:ncbi:10090">transgenic mice</span>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 575 580 <span type="species:ncbi:9606">human</span>
###xml 601 607 <span type="species:ncbi:10090">murine</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 724 729 <span type="species:ncbi:9606">human</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
The effect of Rep1 on human SNCA-mRNA levels was also studied in whole-blood samples from these transgenic mice (n = 72), as obtained prior to decapitation. The quantification of SNCA proteins in peripheral blood is of interest to the PD field as a potential biomarker (32), as well as from the perspective of tissue-specific gene expression (34). To this end, we carried out a similar study in mouse blood samples to the one described above for the brain; in contrast to the brain analysis, ubiquitously expressed Gapdh was used as the endogenous reference probe to measure human SNCA-mRNA levels in murine samples (Fig. 6A). We found that mice carrying the PD risk-associated allele Rep1-261 bp showed, on average, higher human SNCA-mRNA levels in blood specimens obtained from the orbital sinus compared with mice transgenic for the protective genotype with allele Rep1-259 bp (0.1 versus 0.005-fold expression on average relative to the endogenous Gapdh mRNA levels, respectively) (Fig. 6B). However, the variability within each genotype was quite large, and the median values showed no significant differences (Fig. 6B). No correlation was observed between individual blood SNCA-mRNA levels and gender (P = 0.221).
###end p 22
###begin p 23
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 114 115 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 198 202 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 226 231 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 282 286 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 297 302 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 391 395 383 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 400 405 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 518 519 506 507 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 542 546 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 618 623 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 658 666 646 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 711 715 695 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 842 846 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 910 914 894 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 967 971 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1034 1035 1018 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 276 281 <span type="species:ncbi:9606">human</span>
###xml 291 296 <span type="species:ncbi:10090">mouse</span>
###xml 536 541 <span type="species:ncbi:9606">human</span>
###xml 612 617 <span type="species:ncbi:10090">mouse</span>
###xml 705 710 <span type="species:ncbi:9606">human</span>
###xml 752 757 <span type="species:ncbi:10090">mouse</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
Effect of the SNCA-Rep1 promoter genotypes on human SNCA-mRNA expression levels in transgenic mouse whole blood. (A) Validation curve of the Delta real-time assay for relative quantization of human SNCA-mRNA relative to mouse Gapdh-mRNA in blood. Relative efficiency plots of human-SNCA and mouse-Gapdh were formed by plotting the log input amount (ng of total RNA) versus the DeltaCt = [Ct(SNCA)-Ct(Gapdh)]. The slope is 0.1, which indicated the validation of the DeltaCt calculation in the range of 0.1-100 ng RNA. (B) Fold levels of human SNCA-mRNA were assayed by real-time RT-PCR and calculated relative to mouse Gapdh-mRNA reference control using the 2-DeltaCt method. No detectable products of the human SNCA-mRNA reaction were observed when WT mouse blood-cDNA was used as template. The risk genotype, 261/261, correlates with higher SNCA-mRNA levels than the protective genotype, 259/259. The deleted SNCA-Rep1 genotype shows no significant correlation with SNCA-mRNA levels in comparison with genotypes 261/261 and 259/259 (P = 0.524). In total, 72 mice were analyzed; for each genotype (261/261, 259/259 and Delta/Delta), the box plot represents the analysis performed using two transgenic lines, 12 animals from each line (6 males and 6 females); overall, 24 whole-blood samples (per genotype) were each repeated twice, independently. The average values are presented by 'X'. The box plot shows the median (horizontal line inside the box) and the 25th and 75th percentiles (horizontal borders of the box). The range between the 25th and 75th percentiles is the interquartile range. The whiskers show the minimal and maximal values inside the main data body.
###end p 23
###begin p 24
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F6">6</xref>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 852 854 852 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C34">34</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C35">35</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C27">27</xref>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
We also assessed the contributory role (if any) of the Rep1 region to SNCA-mRNA levels in these blood specimens. In contrast to the results obtained in brain homogenates, we did not observe an apparent Rep1 effect on SNCA-mRNA expression levels in these hematological specimens; there was no significant difference in SNCA-mRNA levels in blood from mice carrying the deleted Rep1 allele (0.046-fold on average relative to the endogenous Gapdh mRNA) when compared with the average value of mice carrying either allele (261 or 259) at the SNCA-Rep1 site (0.05-fold on average; P = 0.524). Here again, the median values did not differ among the three genotypes (Fig. 6B). These findings suggested that the Rep1 element did not appear to regulate the expression level of SNCA gene in the hematological precursor cells that generated these blood specimens (34,35), thereby suggesting a neuro-specific effect for the Rep1 element (27).
###end p 24
###begin p 25
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
In order to determine whether SNCA-mRNA levels in the blood are individually concordant with mRNA levels recorded in the brain, we carried out several correlation studies in these mice; however, the comparison of the relative SNCA-mRNA levels between the brain and blood samples from each individual animal showed no correlation.
###end p 25
###begin title 26
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Effects of Rep1 variants on human SNCA protein concentrations in mouse blood
###end title 26
###begin p 27
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 556 557 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 630 634 630 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F7">7</xref>
###xml 1279 1280 1257 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F7">7</xref>
###xml 1628 1630 1602 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C34">34</xref>
###xml 1631 1633 1605 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C35">35</xref>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 117 132 <span type="species:ncbi:10090">transgenic mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
###xml 544 549 <span type="species:ncbi:9606">human</span>
###xml 684 689 <span type="species:ncbi:9606">human</span>
###xml 740 745 <span type="species:ncbi:9606">human</span>
###xml 750 755 <span type="species:ncbi:10090">mouse</span>
###xml 1103 1108 <span type="species:ncbi:10090">mouse</span>
###xml 1310 1315 <span type="species:ncbi:9606">human</span>
###xml 1397 1401 <span type="species:ncbi:10090">mice</span>
###xml 1450 1454 <span type="species:ncbi:10090">mice</span>
###xml 1507 1512 <span type="species:ncbi:9606">human</span>
###xml 1550 1555 <span type="species:ncbi:10090">mouse</span>
###xml 1611 1616 <span type="species:ncbi:9606">human</span>
###xml 1751 1756 <span type="species:ncbi:9606">human</span>
###xml 1875 1879 <span type="species:ncbi:10090">mice</span>
We next analyzed the effect of Rep1 on human SNCA protein levels in sister aliquots of the same blood specimens from transgenic mice carrying these three different alleles. To this end, we examined blood lysates from age- and gender-matched mice by the same two ELISA protocols employed above () and corrected the SNCA signal for the gene copy number in each animal. The parallel analysis of blood lysates (n = 72) on the same ELISA plate by an operator blinded to the genotype revealed no statistically significant difference in the levels of human SNCA (P = 0.477) among the six transgenic lines that carried the three distinct SNCA-Rep1 genotypes (Fig. 7A). In accordance with the human-specific values, the total SNCA concentration (of human and mouse SNCA) in these blood specimens did not reveal a significant difference in the Rep1-261 bp-carrying animals (Rep1-261 bp; total SNCA 20.68 +/- 2.96 ng/microl) when compared with the other two genotypes (Rep1-259 bp 19.59 +/- 3.14 ng/microl; Delta-Rep1 18.60 +/- 2.33 ng/microl) (). After copy number correction, the total SNCA concentration in the mouse blood showed a trend for the reduction in the PD risk-associated Rep1-261 bp animals, but the variability, in particular within the Rep1-259 bp genotype, was large (Fig. 7B). The calculated ratios of 'human-to-total-SNCA levels following gene copy number correction' were 0.85 in 261/261 mice, 1.23 in 259/259 animals and 1.28 in Delta-Rep1 mice. However, it is important to state that the overall human SNCA protein concentrations in these mouse blood specimens were markedly lower than in comparable human specimens (34,35), which may explain the failure to detect any consistent and meaningful variations. These results suggested that the human SNCA protein levels in these blood specimens did not parallel the expression levels found in the brains from the same mice.
###end p 27
###begin p 28
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 4 5 4 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</bold>
###xml 104 105 104 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 385 389 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snca</italic>
###xml 682 683 674 675 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 158 163 <span type="species:ncbi:10090">mouse</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 334 339 <span type="species:ncbi:9606">human</span>
###xml 399 403 <span type="species:ncbi:10090">mice</span>
###xml 531 536 <span type="species:ncbi:10090">mouse</span>
###xml 757 762 <span type="species:ncbi:10090">mouse</span>
###xml 865 870 <span type="species:ncbi:10090">mouse</span>
###xml 880 885 <span type="species:ncbi:9606">human</span>
SNCA-Rep1 expansion does not lead to detectable SNCA protein concentration differences in mouse blood. (A) Quantification of human SNCA protein in transgenic mouse blood homogenates using sandwich ELISA [hSA-3/211-B] and 384-well plate format (triplicates; 50 microl/well); a total of 72 mice were analyzed. Signals were specific for human SNCA protein because whole blood from WT and snca-knockout mice did not generate ELISA signals above the background (). Values were then corrected for the calculated gene copy number in each mouse line and grouped according to the three genotypes examined, i.e. Rep1-261 bp; Rep1-259 bp; Delta-Rep1 (ratio: female:male, 50:50 in all lines). (B) Quantification of total SNCA protein concentration levels in transgenic mouse blood was carried out with sandwich ELISA [hSA3/Syn1-B] and 384-well plates. This ELISA measures both mouse snca and human SNCA proteins (); values (in ng/microl) were then corrected for gene copy number.
###end p 28
###begin title 29
DISCUSSION
###end title 29
###begin p 30
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C36">36</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C37">37</xref>
###xml 1140 1144 1140 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1340 1344 1328 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1363 1370 1351 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 284 290 <span type="species:ncbi:9606">humans</span>
###xml 813 818 <span type="species:ncbi:9606">human</span>
###xml 878 883 <span type="species:ncbi:9606">human</span>
###xml 916 921 <span type="species:ncbi:10090">mouse</span>
###xml 940 945 <span type="species:ncbi:10090">mouse</span>
###xml 1112 1117 <span type="species:ncbi:9606">human</span>
###xml 1334 1339 <span type="species:ncbi:9606">human</span>
This study describes a novel approach in the field of neurodegenerative diseases for examining the role of genetic variations positioned in non-coding, putative regulatory regions of the human genome by aiming to identify causality for regulatory variants. Gene expression studies in humans, especially when they involve the analysis of post-mortem brain, often introduce several confounding variables, e.g. differences in genetic background, age, environmental exposures (including pharmacotherapy), length of illness and importantly, variability in post-mortem interval and tissue handling. All of these factors can affect mRNA and protein stability, and thus their measureable abundance (36,37). In order to overcome the combination of these confounding factors involved in studying mRNA and protein levels in human post-mortem tissue, we took the novel approach of studying human gene expression in a transgenic mouse model. Transgenic mouse models have been used, almost exclusively, to study the effect of mutations in coding gene sequences. Here, we generated a transgenic model, which carries the entire human genomic region of the SNCA gene, to study the effect of a variation located approximately10 kb upstream of the transcription start site within the putative promoter/enhancer region and to dissect its contribution to human SNCA expression levels in vivo.
###end p 30
###begin p 31
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C16">16</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C19">19</xref>
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C38">38</xref>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 629 633 629 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 788 792 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1085 1089 1085 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1144 1148 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1178 1182 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1263 1267 1263 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1295 1299 1295 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1335 1339 1335 1339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1918 1922 1918 1922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1977 1978 1977 1978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2125 2129 2125 2129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2177 2181 2177 2181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2419 2423 2419 2423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2458 2462 2458 2462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 2670 2671 2670 2671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C6">6</xref>
###xml 522 530 <span type="species:ncbi:9606">patients</span>
###xml 1210 1215 <span type="species:ncbi:10090">mouse</span>
###xml 1329 1334 <span type="species:ncbi:9606">human</span>
###xml 1394 1409 <span type="species:ncbi:10090">transgenic mice</span>
A critical question concerning the molecular pathogenesis of PD is what contributory role, if any, is played by the SNCA gene in sporadic PD. Several studies conferred an association of common SNCA polymorphisms in the 5' and 3' regions of the gene locus with PD susceptibility (16-19) (38); however, the causal variant/s and hence the underlying mechanism/s remained elusive. We hypothesized that altered regulation of SNCA gene expression levels is important in the development of sporadic PD in a significant subset of patients; these include subjects who do not express a mutant SNCA protein and who do not carry an elevated SNCA gene dosage in their genome. One important mechanism that modulates gene expression levels is transcriptional efficiency. Markers across the 5' region of SNCA that were associated with increased odds ratio to develop PD are in almost complete linkage disequilibrium with each other, which makes pinpointing the biologically relevant variant within an associated 5' region challenging. In this study, we provide evidence for a contributory role of the SNCA-Rep1 variant in the transcriptional regulation of the SNCA gene and in their effects on SNCA-mRNA and protein levels in mouse brain. We found a positive correlation between SNCA-Rep1 allele lengths at the SNCA enhancer/promoter region and human SNCA-mRNA as well as protein levels in the brains of these transgenic mice. Although we are cognizant of the potential limitations by using whole-brain homogenates rather than region-specific specimens (that are of relevance to PD pathogenesis), we purposefully sought to minimize any introduction of inaccuracies stemming from variability in tissue dissection and to accommodate a larger number of animals in our quantitative assays. Our results show that allele Rep1-261 bp, which confers increased risk to develop late-onset, sporadic PD, was significantly correlated with higher SNCA levels relative to the protective allele Rep1-259 bp (P < 0.0001). Intriguingly, our collective data suggest that the carrier status of Rep1-261 bp homozygosity within an otherwise WT complement of two SNCA gene copies results in a 1.7-fold elevation of SNCA-mRNA and a 1.25-fold elevation in the protein level, suggesting that variability in translational efficiency had only a limited effect. Therefore, Rep1-261 bp homozygosity may be functionally equivalent to the situation of subjects with SNCA locus duplication who carry three SNCA copies, which results in 1.5-fold elevation. We therefore speculate that Rep1-261 bp homozygosity confers a critical gain-of-function mechanism in PD penetrance and in the expressivity of synucleinopathies (6).
###end p 31
###begin p 32
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C28">28</xref>
###xml 774 779 774 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 988 993 988 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 354 359 <span type="species:ncbi:9606">human</span>
###xml 795 800 <span type="species:ncbi:9606">human</span>
###xml 842 847 <span type="species:ncbi:10090">mouse</span>
Although the biological effect of the Rep1 expansion was observed in the most relevant organ to PD expression, i.e. the brain, its contribution appeared specific because its enhancer role was not recorded in the corresponding blood specimens. Of note, Fuchs et al. (28) recently reported a positive genotype-to-phenotype effect for Rep1 repeat length in human blood samples, where homozygotes of the protective, shorter allele had lower concentrations of SNCA protein in peripheral blood mononuclear cells; intriguingly, and in agreement with our finding, these authors observed no effect at the mRNA level in peripheral blood. At the current time, we cannot exclude a modulatory effect by the Rep1 genotype on SNCA protein levels in peripheral blood (as suggested by Fuchs et al.), because the human protein concentrations in our transgenic mouse blood were unexpectedly low, which could have put any significant variation below the limit of detection. The discrepancy between the Fuchs et al. and our study may also be explained by a variety of other factors; chief among them are the differences in donor species and sample sizes, the methods of blood collection and processing and, last but not least, the differences between the ELISA protocols employed.
###end p 32
###begin p 33
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 178 180 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C39">39</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C40">40</xref>
###xml 709 711 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C11">11</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C41">41</xref>
###xml 781 788 781 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 967 971 967 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C27">27</xref>
###xml 797 802 <span type="species:ncbi:10090">mouse</span>
The quantification of peripheral SNCA-mRNA levels together with the characterization of the Rep1 genotype has also been explored in the context of alcohol use-related disorders (39); the most recent study suggests an independent (but not a pairwise) association of Rep1 genotype and alcohol abuse with PD risk (40). Clearly, larger cross-sectional and longitudinal studies of carefully collected cohorts and validated, standardized protocols are now needed to further investigate these neuropsychatric conditions. This aspect is particularly relevant for PD biomarker efforts that seek to correlate variations in the transcriptome and/or proteome of venous blood with the clinical phenotype of living donors (11,41). Overall, the observed neuro-specific effect of the Rep1 element in vivo using a mouse model is consistent with our previous cellular results. Using a luciferase reporter system, we had observed that the construct harboring the expanded allele at the SNCA-Rep1 site generated the highest luciferase activity specifically in dopaminergic SH-SY5Y neuroblastoma cells (27).
###end p 33
###begin p 34
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 231 235 231 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C25">25</xref>
###xml 1029 1033 1029 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1057 1059 1057 1059 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C42">42</xref>
###xml 1060 1062 1060 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C43">43</xref>
###xml 725 740 <span type="species:ncbi:10090">transgenic mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 889 894 <span type="species:ncbi:9606">human</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
Our results lend support for the overall biological significance of SNCA-Rep1, thereby suggesting that many of the observed associations between the SNCA 5' region and PD susceptibility could possibly be explained by variations in SNCA-Rep1 genotype. We predict that the association of the 261 bp-long risk allele with sporadic PD is conferred by direct upregulation of SNCA transcription, and that the protective allele 259 bp acts through the lowering of its expression rate. Here, we chose to focus on the two most common Rep1 alleles; we acknowledge the role that other variants may play, such as the rare PD-associated 263 bp-long Rep1 variant (25). Additional Rep1 allelic variants will be analyzed using newly created transgenic mice in future studies. Likewise, it will be of interest to determine whether our PAC mice will develop any neuropathological and behavioral features of human synucleinopathies toward the end of their lifespan that are currently not seen in those transgenic models that are based solely on an SNCA cDNA construct design (42,43). At the age of 8 weeks, we have observed no readily recognizable alteration in the behavior of the mice used in this study.
###end p 34
###begin p 35
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C44">44</xref>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 484 487 484 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C34">34</xref>
In our previous work, we identified a transcription factor, poly(ADP-ribose) transferase/polymerase-1 (PARP-1, MIM 173870), which specifically bound to Rep1 and modulated SNCA transcription (44). It will be interesting to explore whether the variability in SNCA regulation (as mediated by Rep1 alleles) rests on altered binding efficiency of PARP-1 to Rep1 sequences that vary in length. Alternatively, our observed Rep1 expansion effect could also be explained by interaction/s with cis-acting elements during chromatin unfolding, which precedes SNCA gene transcription, for example, with the recently discovered GATA motif within intron 1. This intronic GATA site is selectively occupied by GATA-2 (MIM 137295) protein in neurons and by GATA-1 (MIM 305371) in erythroid cells (34).
###end p 35
###begin p 36
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C45">45</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C46">46</xref>
###xml 365 372 365 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C47">47</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C48">48</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C10">10</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C11">11</xref>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C47">47</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C49">49</xref>
###xml 627 629 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C50">50</xref>
###xml 1050 1054 1050 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 15 20 <span type="species:ncbi:10090">mouse</span>
###xml 347 352 <span type="species:ncbi:9606">human</span>
###xml 1044 1049 <span type="species:ncbi:9606">human</span>
The transgenic mouse approach we have pursued here could serve as a valuable model system for a variety of future studies in the PD field, including those that examine gene-environment interactions, such as the protective effects of smoking (45,46); our approach may also serve proof of concept studies, such as those that target the reduction of human SNCA levels in vivo either through the specific modulation of mRNA translation (47) or through the acceleration of SNCA degradation by candidate enzymes (33,48). The unequivocal evidence that puts increased steady states of SNCA at the center of PD development (10,11,47,49,50) emphasizes the importance of studies like ours in the pursuit of three important (and related) research goals: to better dissect the pathogenesis of synucleinopathies; to develop earlier markers of risk and disease state; and to find validated drug targets near the root of Parkinson's to initiate cause-directed therapy in the future. Further exploration of the mechanism by which Rep1 allele expansion enhances human SNCA gene transcription in at-risk neurons may serve all three goals.
###end p 36
###begin title 37
MATERIALS AND METHODS
###end title 37
###begin title 38
Recombineering PAC
###end title 38
###begin p 39
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C51">51</xref>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 303 305 303 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 308 309 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 313 315 313 315 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 319 320 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 324 326 324 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sub>
###xml 393 395 393 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 398 399 398 399 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 403 405 403 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 409 410 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 414 416 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 519 523 519 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C20">20</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C25">25</xref>
###xml 815 831 815 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 841 845 841 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 914 918 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 997 999 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C27">27</xref>
###xml 1046 1050 1042 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 93 101 <span type="species:ncbi:9606">Children</span>
###xml 211 216 <span type="species:ncbi:9606">Human</span>
###xml 490 495 <span type="species:ncbi:9606">human</span>
###xml 815 831 <span type="species:ncbi:562">Escherichia coli</span>
A PAC containing the 146 kb PAC 27M07 (RPCI human male PAC library, BAC/PAC Resource Center, Children's Hospital, Oakland, CA, USA) was used as the substrate for recombineering by the method of Lee et al. (51). Human genomic DNA spanning the SNCA-Rep1 locus and containing either the 261 bp allele ((TC)10(T)2(TC)10(TA)8(CA)11, heretofore referred to as Rep1-261 bp) or the 259 bp allele ((TC)10(T)2(TC)10(TA)8(CA)10, heretofore referred to as Rep1-259 bp) was isolated by PCR of anonymous human DNA of the appropriate SNCA-Rep1 genotype (Centre d'Etude du Polymorphisme Humaine). Alleles were defined according to the length of the PCR product in concordance to the conventional nomenclature (20,25). The PCR fragments were sequenced and then cloned into a recombineering vector for site-directed recombination in Escherichia coli into the SNCA-Rep1 locus in PAC 27M07. A third PAC was recombineered in which the SNCA-Rep1 repeat had been precisely deleted, heretofore referred to as Delta-Rep1 (27). All three PACs were identical except at the SNCA-Rep1 locus.
###end p 39
###begin title 40
Generation of transgenic lines
###end title 40
###begin p 41
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1086 1090 1074 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snca</italic>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 248 252 <span type="species:ncbi:10090">Mice</span>
###xml 272 277 <span type="species:ncbi:9606">human</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
###xml 803 807 <span type="species:ncbi:10090">mice</span>
###xml 1005 1010 <span type="species:ncbi:10090">mouse</span>
###xml 1079 1085 <span type="species:ncbi:10090">murine</span>
###xml 1163 1167 <span type="species:ncbi:10090">mice</span>
The three different constructs were microinjected into the pronuclei of fertilized FVB/N mouse ova by standard techniques. F1s heterozygous for the intact human PAC transgenes were crossed to produce homozygotes for each allelic variant transgene. Mice homozygous for the human transgene harboring 261 and 259 bp SNCA-Rep1 alleles and the deleted allele are referred to as 261/261, 259/259, Delta/Delta mice, respectively. Of note, one of the Delta-Rep1 lines, 'B', was non-viable probably due to insertion site effect, thus for this line, the analysis was performed using heterozygous mice, and the transgene copy number was corrected accordingly (see below). Two lines were generated from each genotype (i.e. a total of six lines). Six male and six female F2s homozygous from each transgenic line, 72 mice in total, were sacrificed at the age of 8 weeks for sample collection. Blood was collected from the orbital sinus, and subsequently, the whole brain was harvested. It is important to note that all mouse lines shared an identical genetic background, which included the WT murine snca locus, and were reared in the same environment. In addition, all of the mice underwent identical blood collection and brain-harvesting procedures.
###end p 41
###begin title 42
###xml 16 31 <span type="species:ncbi:10090">transgenic mice</span>
DNA analysis of transgenic mice
###end title 42
###begin p 43
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 976 978 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C52">52</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C53">53</xref>
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 515 520 <span type="species:ncbi:9606">human</span>
###xml 551 556 <span type="species:ncbi:10090">mouse</span>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
We used DNA from mouse tails to confirm the founders. The SNCA-Rep1 genotypes were verified by direct sequence analysis of the polymorphic repeat and its flanking region. The intactness of the PAC transgenes in each founder animal and its transmission to the F1 generation were assayed by a routine series of 10 PCR assays along the transgene sequence. Primer sequences and PCR conditions for genotyping are available upon request. FISH was used to estimate transgene copy number in the F1 generation. Briefly, the human-PAC targeting construct and a mouse BAC covering comparable size sequence from mouse chromosome 9 were used as probes. Interphase preparations from leukocytes and metaphase preparations from spleen cells were generated by standard air-drying technique, and FISH was performed with labeled DNA prepared by nick translation using spectrum orange-dUTP (red) or spectrum green-dUTP (green) (Vysis, Downers Grove, IL, USA) essentially as described previously (52,53). On each slide, 100 ng of labeled probe was applied. Ten microliters of a hybridization mixture containing the labeled DNA in 50% formamide, 2x SSC and 10% dextran sulfate were denatured at 75degreesC for 10 min and then incubated at 37degreesC for 30 min for preannealing. Slides were denatured and hybridized for at least 18 h and counterstained with DAPI-Antifade before viewing. The relative number of the transgene-DNA copies was estimated by comparison of the signal intensity from the transgenic versus the endogenous probes.
###end p 43
###begin p 44
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Routine genotyping of all the newborn (F1 and F2 generations mice) was performed by PCR with one of the primer sets used in the founder analysis. To differentiate between F2 homozygous and heterozygous animals, we performed FISH analysis as described above.
###end p 44
###begin title 45
Determination of the relative transgene copy number
###end title 45
###begin p 46
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 630 632 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C29">29</xref>
###xml 822 823 816 817 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 841 842 835 836 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 918 922 908 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 1488 1489 1454 1455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 1565 1578 1531 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;&#916;Ct</sup>
###xml 2141 2144 2093 2096 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Act</italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 177 182 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 416 421 <span type="species:ncbi:9606">human</span>
###xml 657 662 <span type="species:ncbi:9606">human</span>
###xml 687 692 <span type="species:ncbi:10090">mouse</span>
###xml 2123 2128 <span type="species:ncbi:10090">mouse</span>
###xml 2315 2320 <span type="species:ncbi:10090">mouse</span>
To assay for transgene dosage, genomic DNA was extracted from F1 mice liver by standard Qiagen protocol and quantitative real-time PCR targeting two different regions along the human PAC, i.e. human-SNCA exons 2 and 6, was performed on the ABI Prism 7900 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The beta-actin gene was amplified as an endogenous reference for the quantification of the human-SNCA transgene using ABI MGB probe and primer set assay-by-demand ID Mm00607939_s1 (Applied Biosystems). The assay-by-design primers and probes sequences for SNCA exon 2 and exon 6 were described previously (29). TaqMan MGB probes for human SNCA exon 2, exon 6 and mouse beta-actin were labeled with 6-FAM. PCR was carried out with TaqMan Universal PCR Master Mix using 10 or 50 ng genomic DNA, 900 nm primers and 250 nm probes in a total reaction volume of 20 microl. The reactions for the test SNCA loci and the reference beta-actin locus were prepared and run in parallel. PCR cycling conditions were as follows: 95degreesC for 10 min, 95degreesC for 15 s and 60degreesC for 1 min (40 cycles). Each genomic DNA sample was assayed in two different gDNA amounts (10 and 50 ng), running each amount in duplicate and the entire assay was repeated twice. The cycle in the log phase of PCR amplification at which a significant fluorescence threshold was reached (Ct) was used to quantify each exon. For each transgenic line, the dosage of PAC transgene relative to beta-actin and normalized to control DNA was determined for each exon using the 2-DeltaDeltaCt method. A value was considered as a single copy if it was within the range of 0.8-1.2. Greater copy numbers were calculated as ratios relative to a single copy value. A standard curve was generated using gDNA 0.1, 1, 10, 25, 50, 100 and 150 ng, and a regression curve was calculated for each assay (exon 2 and exon 6). In addition, the slope of the relative efficiency plot for SNCA exons 2 and 6 and the reference control beta-actin was determined to validate the assays (). The transgene copy number was calculated relative to the endogenous mouse beta-actin (Act) gene, and all copy number variations were expressed relative to having one copy number per haploid genome (ratio of 0.8-1.2 for homozygous transgene relative to diploid mouse beta-actin gene). The copy number of the only heterozygous Delta-Rep1 transgenic line 'B' was adjusted accordingly.
###end p 46
###begin title 47
RNA extraction and cDNA synthesis
###end title 47
###begin p 48
Total RNA was extracted from half whole brain and whole blood (200 microl) using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) followed by purification with RNeasy Kit (Qiagen, Valencia, CA, USA) following the manufacturer's protocol. RNA concentration was determined spectrophotometrically at 260 nm, and the 260/280 nm ratio determined the quality of the purification. In addition, the quality of the sample and the lack of significant degradation products were confirmed on an Agilent Bioanalyzer. Next, cDNA was synthesized using MultiScribe RT enzyme (Applied Biosystems) under the following conditions: 10 min at 25degreesC and 120 min at 37degreesC.
###end p 48
###begin title 49
RT-PCR and real-time PCR
###end title 49
###begin p 50
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
The expression of SNCA-RNA in the brain tissues of F1 generation mice was determined for each line by RT-PCR using the forward primer 5'-CATGGATGTATTCATGAAAGG-3' and reverse primer 5'-GAGTGTAGGGTTAATGTTCC-3'.
###end p 50
###begin p 51
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C14">14</xref>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp)</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C14">14</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C44">44</xref>
###xml 792 796 768 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 891 894 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 992 997 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 1163 1167 1139 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 75 90 <span type="species:ncbi:10090">transgenic mice</span>
###xml 321 326 <span type="species:ncbi:10090">mouse</span>
###xml 435 440 <span type="species:ncbi:10090">mouse</span>
###xml 1157 1162 <span type="species:ncbi:9606">human</span>
###xml 1203 1208 <span type="species:ncbi:9606">human</span>
###xml 1272 1277 <span type="species:ncbi:10090">mouse</span>
Real-time PCR was used to quantify human SNCA-mRNA levels in F2 generation transgenic mice as described previously (14). Briefly, duplicates of each sample were assayed by relative quantitative real-time PCR using the ABI 7900 for the analysis of the level of SNCA message when compared in brain tissues to mRNA-encoding mouse synaptophysin (Syp), a presynaptic protein that has similar expression pattern to SNCA, and in blood to the mouse ubiquitous gene, glyceraldehyde-3-phosphate dehydrogenase (Gapdh), as internal references (14,44). Each cDNA (10 ng) was amplified in duplicate using TaqMan Universal PCR master mix reagent (Applied Biosystems) and the following conditions: 2 min at 50degreesC, 10 min at 95degreesC, 40 cycles: 15 s at 95degreesC, and 1 min at 60degreesC. The target SNCA cDNA was amplified using ABI MGB probe and primer set assay ID Hs00240906_m1, normalized to a Syp RNA control (ABI MGB probe and primer set assay ID Mm00436850_m1) for the brain samples and to a Gapdh RNA control (ABI MGB probe and primer set assay ID Mm99999915_g1) for the blood samples (Applied Biosystems). As a negative control for the specificity of the human-SNCA 'assay-on-demand' amplification of human message, we used whole-brain and blood RNA samples from WT FVB mouse. Data were analyzed with a threshold set in the linear range of amplification. The cycle number at which any particular sample crossed that threshold (Ct) was then used to determine the fold difference.
###end p 51
###begin p 52
###xml 35 43 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;&#916;Ct</sup>
###xml 59 63 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 68 71 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 75 80 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 187 192 179 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 232 236 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Snca</italic>
###xml 270 274 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eno2</italic>
###xml 309 312 301 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 508 525 500 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh, Snca, Eno2</italic>
###xml 530 533 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 660 664 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 782 785 774 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 796 800 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 832 837 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 848 852 840 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 982 983 974 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F3">3</xref>
###xml 989 990 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP265F6">6</xref>
###xml 1033 1036 1025 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 1041 1046 1033 1038 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gapdh</italic>
###xml 1202 1205 1194 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 1210 1214 1202 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eno2</italic>
###xml 1273 1276 1265 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syp</italic>
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
###xml 253 258 <span type="species:ncbi:10090">mouse</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 554 559 <span type="species:ncbi:10090">mouse</span>
###xml 776 781 <span type="species:ncbi:10090">mouse</span>
###xml 790 795 <span type="species:ncbi:9606">human</span>
###xml 826 831 <span type="species:ncbi:10090">mouse</span>
###xml 842 847 <span type="species:ncbi:9606">human</span>
###xml 1196 1201 <span type="species:ncbi:10090">mouse</span>
Fold difference was calculated as 2-DeltaCt; DeltaCt = [Ct(SNCA)-Ct(Syp or Gapdh)]. Of note is that three internal controls were compared: mouse glyceraldehyde-3-phosphate dehydrogenase (Gapdh Mm99999915_g1), mouse alpha-synuclein (Snca Mm00447331_m1), mouse enolase 2 (Eno2 Mm00469062_m1) and synaptophysin (Syp Mm00436850_m1) using different total RNA amounts (0.1-100 ng) from whole-brain tissue and whole-blood samples of a transgenic mouse. For assay validation, we used standard curves for each assay (Gapdh, Snca, Eno2 and Syp) using a transgenic mouse whole-brain and whole-blood RNA samples. In addition, the slope of the relative efficiency plot for SNCA and each internal control was determined to validate the assays. The slope in the relative efficiency plot for mouse Syp and human SNCA in brain (0.045) and for mouse Gapdh and human SNCA in blood (0.1) were the smallest, showing a standard value required for the validation of the relative quantitative method (Figs 3A and 6A). Thus, for the extended study, we chose Syp and Gapdh as the internal control for the whole brain and blood, respectively. In addition, for a subset group of brain samples, we used the geometric mean of mouse Syp and Eno2 as a normalization control and confirmed the selection of Syp as a representative normalization control for the entire brain set.
###end p 52
###begin title 53
Western blotting and antibodies
###end title 53
###begin p 54
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C31">31</xref>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
###xml 164 169 <span type="species:ncbi:9606">human</span>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 384 389 <span type="species:ncbi:10090">mouse</span>
###xml 394 399 <span type="species:ncbi:9606">human</span>
The expression of human SNCA protein in the brain tissues was determined by western blotting with the mouse mAb LB509 (Zymed) and mAb 211 that are specific for the human orthologue of SNCA, with mAb Syn-1 (Transduction Labs) and hSA3. The latter is a polyclonal Ab raised and affinity-purified against full-length, human SNCA, as described (33). Syn-1 and hSA3 Ab react with both the mouse and human orthologues of SNCA (31).
###end p 54
###begin p 55
###xml 83 84 83 84 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 108 109 108 109 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 299 300 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 626 627 616 617 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 638 639 628 629 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
###xml 677 688 <span type="species:ncbi:3704">horseradish</span>
###xml 708 712 <span type="species:ncbi:9925">goat</span>
###xml 718 723 <span type="species:ncbi:10090">mouse</span>
###xml 926 931 <span type="species:ncbi:10090">mouse</span>
###xml 1023 1028 <span type="species:ncbi:9606">human</span>
Whole brains from 2- to 3-month-old mice were homogenized in 10-fold volume of 50 mm Tris-HCl, pH 7.5, 150 mm NaCl, 1% Nonidet P-40, in the presence of a protease inhibitor cocktail (Sigma, St Louis, MO, USA) using a hand-held motorized pestle. After centrifugation to remove particulates at 100 000g (30 min; 4degreesC), total protein concentrations were determined by the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA), and 20 microg of each sample was run on 15% Tris-glycine SDS-PAGE. Proteins were transferred to PVDF membranes (Immobilon-P, Millipore, Bedford, MA, USA), and blots were blocked with 2% casein in 0.1 m Tris, 0.2 m NaCl, pH 9.5. Secondary antibody was horseradish peroxidase-coupled goat anti-mouse IgG (Amersham, Chicago, IL, USA), used at 1:10 000. The immunoreactive proteins were detected using the ECL system (Amersham) according to manufacturer's instructions. For the analysis of F1 generation mouse lines, transgene expression was determined by western blots in comparison with recombinant human SNCA (50 ng).
###end p 55
###begin title 56
Enzyme-linked immunoadsorbent assays
###end title 56
###begin p 57
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C34">34</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Snca</italic>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C33">33</xref>
###xml 1001 1005 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">snca</italic>
###xml 1405 1406 1401 1402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1449 1451 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP265C54">54</xref>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 259 264 <span type="species:ncbi:10090">mouse</span>
###xml 269 274 <span type="species:ncbi:9606">human</span>
###xml 848 853 <span type="species:ncbi:10090">mouse</span>
###xml 1006 1011 <span type="species:ncbi:10090">mouse</span>
###xml 1055 1060 <span type="species:ncbi:9606">human</span>
###xml 1135 1140 <span type="species:ncbi:9606">human</span>
###xml 1160 1165 <span type="species:ncbi:10090">mouse</span>
###xml 1248 1253 <span type="species:ncbi:10090">mouse</span>
###xml 1551 1556 <span type="species:ncbi:10090">mouse</span>
###xml 1704 1708 <span type="species:ncbi:10090">mice</span>
SNCA protein levels were assessed using a 384-well-based sandwich ELISA system as described recently in detail (33, 34). For specific quantification of the human orthologue, we employed the Ab sandwich [hSA3/211-B]; for the quantification of total SNCA (i.e. mouse and human combined), we employed the sandwich pair [hSA3/Syn1-B], where 'B' stands for biotinylation). Recombinant protein was used in standard dilutions for the interpolation of SNCA concentration, as described (33). ELISA signals were monitored at 405 nm every 5 min for up to 60 min. Saturation kinetics were examined for the identification of time point(s) where standards and sample dilutions were in the log phase (33). To control inter-assay variability, all samples were run using two different dilutions in triplicate on the same day with the same lot of standards. Also, a mouse WT versus knock-out Snca curve was generated and included as positive and negative control for the [hSA3/Syn1-B] assay (33); both WT and knock-out snca mouse tissue served as negative controls for the human SNCA-specific [hSA3/211-B] assay. The relative concentration estimates of human SNCA in transgenic mouse brain and blood specimens were calculated according to the standard curve. Frozen mouse brains were thawed, weighed (mg), individually homogenized in three volumes (microl) of Triton X-100-containing lysis buffer and centrifuged at 100 000g during 30 min at 4degreesC, as described (54). Note that each round of homogenization included at least one representative from each of the two mouse lines of the three genotypes. Protein concentrations were calculated and equalized prior to loading. Frozen whole-blood specimens from decapitated mice (drawn in EDTA-containing tubes) were thawed, diluted with normal saline-containing Triton X-100 (1%) and protease inhibitors (Roche) and centrifuged before ELISA analysis.
###end p 57
###begin title 58
Statistical analysis
###end title 58
###begin p 59
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 416 420 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 651 655 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SNCA</italic>
###xml 995 996 993 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1151 1152 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 1167 1168 1165 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1286 1291 <span type="species:ncbi:9606">human</span>
SNCA-mRNA fold expression value of each sample was analyzed repetitively and the results of all replicates were averaged. The average values for each sample (12 samples per line) were used to calculate the average fold expression of each of the six lines. All average values were expressed as mean +/- SEM. The significance of the difference between the mRNA measurements of the three strains carrying the different SNCA-Rep1 alleles was analyzed by the one-sided Wilcoxon rank-sum test. Correlations were assessed by linear regression analyses. The general linear model (GLM) method was used to evaluate the effect of the primary explained variable (SNCA-Rep1 genotype) as well as other secondary variable (sex) on the RNA levels. The GLM is a procedure unifying the ordinary linear regression and ANOVA as well as other procedures based on the least square computation such as ANCOVA. Since gender may also show an effect on the RNA levels, it was included in the model as a factor. Where the P-value of the maximal model remains significant, an effect of each single term was estimated calculating the type III sum of squares and the corresponding F-value and its P-value. Protein concentrations of all mice from each line were used to calculate the average protein concentration of human SNCA of each of the six lines, which were expressed as mean mean +/- SEM. All analyses were carried out using STATA/IC10.0 statistical software (StataCorp, College Station, TX, USA).
###end p 59
###begin title 60
AUTHOR CONTRIBUTIONS
###end title 60
###begin p 61
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 417 422 <span type="species:ncbi:9606">human</span>
K.D.C. performed all the experiments and analyses for the DNA dosage and RNA levels; D.G. did the statistical analyses; P.M. performed the western and all ELISA experiments for the protein analyses; C.L. contributed to the genotyping analysis; A.R. and D.J.B. maintained, breed the mice and carried out tissue harvesting; B.M.O. generated, sequenced and analyzed the PAC recombinant clones; O.M.A.E. co-developed the human-specific ELISA; M.G.S. designed and supervised the protein experiments and analyses; O.C.-F. designed and supervised the DNA and RNA experiments and analyses; R.L.N. and O.C.-F. conceived and designed the study; M.G.S., R.L.N. and O.C.-F. drafted and finalized the manuscript.
###end p 61
###begin title 62
SUPPLEMENTARY MATERIAL
###end title 62
###begin p 63
.
###end p 63
###begin p 64
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 64
###begin title 65
[Supplementary Data]
###end title 65
###begin title 66
FUNDING
###end title 66
###begin p 67
###xml 39 79 39 79 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Institute for Genome Sciences and Policy</funding-source>
###xml 117 192 117 192 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Intramural Research Program of the National Human Genome Research Institute</funding-source>
###xml 209 295 209 295 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health/National Institute for Neurological Disorders and Stroke</funding-source>
###xml 310 323 310 323 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5P50-NS038375</award-id>
###xml 333 362 333 362 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Parkinson Research Consortium</funding-source>
###xml 161 166 <span type="species:ncbi:9606">Human</span>
This work was supported in part by the Institute for Genome Sciences and Policy at Duke University (to O.C.-F.); the Intramural Research Program of the National Human Genome Research Institute (to R.L.N); the National Institutes of Health/National Institute for Neurological Disorders and Stroke (grant number 5P50-NS038375) and the Parkinson Research Consortium at the University of Ottawa (to M.G.S.). Funding to pay the Open Access publication charges for this article was provided by the Institute for Genome Sciences and Policy at Duke University (to O.C.-F.).
###end p 67
###begin title 68
REFERENCES
###end title 68
###begin article-title 69
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
###end article-title 69
###begin article-title 70
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
###end article-title 70
###begin article-title 71
The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia
###end article-title 71
###begin article-title 72
Alpha-synuclein locus triplication causes Parkinson's disease
###end article-title 72
###begin article-title 73
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication
###end article-title 73
###begin article-title 74
Genomic investigation of alpha-synuclein multiplication and parkinsonism
###end article-title 74
###begin article-title 75
Alpha-synuclein locus duplication as a cause of familial Parkinson's disease
###end article-title 75
###begin article-title 76
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease
###end article-title 76
###begin article-title 77
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
###end article-title 77
###begin article-title 78
Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications
###end article-title 78
###begin article-title 79
Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication
###end article-title 79
###begin article-title 80
Alpha-synuclein in Lewy bodies
###end article-title 80
###begin article-title 81
Multiple-system atrophy: a new alpha-synuclein disease?
###end article-title 81
###begin article-title 82
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients
###end article-title 82
###begin article-title 83
Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease
###end article-title 83
###begin article-title 84
Alpha-synuclein promoter confers susceptibility to Parkinson's disease
###end article-title 84
###begin article-title 85
Multiple regions of alpha-synuclein are associated with Parkinson's disease
###end article-title 85
###begin article-title 86
Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease
###end article-title 86
###begin article-title 87
{alpha}-Synuclein and Parkinson disease susceptibility
###end article-title 87
###begin article-title 88
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism
###end article-title 88
###begin article-title 89
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 10 15 <span type="species:ncbi:10090">mouse</span>
Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element
###end article-title 89
###begin article-title 90
Alpha-synuclein gene haplotypes are associated with Parkinson's disease
###end article-title 90
###begin article-title 91
Meta-analysis of alpha synuclein/NACP polymorphism in Parkinson's disease in Japan
###end article-title 91
###begin article-title 92
Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease
###end article-title 92
###begin article-title 93
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease
###end article-title 93
###begin article-title 94
Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene
###end article-title 94
###begin article-title 95
Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system
###end article-title 95
###begin article-title 96
Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain
###end article-title 96
###begin article-title 97
No alterations in alpha-synuclein gene dosage observed in sporadic Parkinson's disease
###end article-title 97
###begin article-title 98
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease
###end article-title 98
###begin article-title 99
Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
###end article-title 99
###begin article-title 100
###xml 60 65 <span type="species:ncbi:9606">human</span>
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
###end article-title 100
###begin article-title 101
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration
###end article-title 101
###begin article-title 102
GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein
###end article-title 102
###begin article-title 103
Red blood cells are the major source of alpha-synuclein in blood
###end article-title 103
###begin article-title 104
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human postmortem tissue: what quality markers matter?
###end article-title 104
###begin article-title 105
###xml 43 48 <span type="species:ncbi:9606">human</span>
Quality control for microarray analysis of human brain samples: the impact of postmortem factors, RNA characteristics, and histopathology
###end article-title 105
###begin article-title 106
Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease
###end article-title 106
###begin article-title 107
Joint analysis of the NACP-REP1 marker within the alpha synuclein gene concludes association with alcohol dependence
###end article-title 107
###begin article-title 108
Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study
###end article-title 108
###begin article-title 109
Molecular markers of early Parkinson's disease based on gene expression in blood
###end article-title 109
###begin article-title 110
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders
###end article-title 110
###begin article-title 111
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 34 39 <span type="species:ncbi:9606">human</span>
Neuropathology in mice expressing human alpha-synuclein
###end article-title 111
###begin article-title 112
Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene
###end article-title 112
###begin article-title 113
Exploring gene-environment interactions in Parkinson's disease
###end article-title 113
###begin article-title 114
Variations in gender ratios support the connection between smoking and Parkinson's disease
###end article-title 114
###begin article-title 115
In vivo silencing of alpha-synuclein using naked siRNA
###end article-title 115
###begin article-title 116
Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity
###end article-title 116
###begin article-title 117
###xml 2 12 2 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 2 12 <span type="species:ncbi:7227">Drosophila</span>
A Drosophila model of Parkinson's disease
###end article-title 117
###begin article-title 118
The role of alpha-synuclein in Parkinson's disease: insights from animal models
###end article-title 118
###begin article-title 119
###xml 19 35 19 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 19 35 <span type="species:ncbi:562">Escherichia coli</span>
A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA
###end article-title 119
###begin article-title 120
###xml 54 57 <span type="species:ncbi:9615">dog</span>
Gene localization and syntenic mapping by FISH in the dog
###end article-title 120
###begin article-title 121
###xml 26 31 <span type="species:ncbi:9606">human</span>
Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries
###end article-title 121
###begin article-title 122
Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin
###end article-title 122
###begin article-title 123
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 39 44 <span type="species:ncbi:9606">human</span>
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation
###end article-title 123

